tailieunhanh - Low-dose aspirin and survival from lung cancer: A population-based cohort study

Preclinical evidence suggests that aspirin may inhibit lung cancer progression. In a large cohort of lung cancer patients, we investigated whether low-dose aspirin use was associated with a reduction in the risk of lung cancer-specific mortality. |

TÀI LIỆU LIÊN QUAN
TỪ KHÓA LIÊN QUAN